Tiziana Life Sciences (TLSA) Assets Growth (3y) (2020 - 2025)

Tiziana Life Sciences (TLSA) Assets Growth (3y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,102.16 Bn 67,101.87 Bn -
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn -
3 Akari Therapeutics 959.56 Bn 959.56 Bn -
4 BeOne Medicines 472.39 Bn 467.60 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.08 Bn 114.83 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn
7 Belite Bio 62.34 Bn 62.34 Bn -
8 Argenx Se 55.97 Bn 50.78 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.47 Bn 34.46 Bn 959.66 Mn
10 Tiziana Life Sciences 111.14 Mn 107.13 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -24.28%
Jun 30, 2025 -22.11%
Dec 31, 2024 -38.63%
Jun 30, 2024 -42.56%
Dec 31, 2023 -43.72%
Jun 30, 2023 10.16%
Dec 31, 2022 125.00%
Jun 30, 2022 135.26%
Dec 31, 2021 91.11%
Jun 30, 2021 218.63%
Dec 31, 2020 204.09%